Armata Pharmaceuticals (ARMP) Shares Outstanding (2013 - 2026)

Armata Pharmaceuticals (ARMP) has 9 years of Shares Outstanding (Entity) data on file, last reported at $36.6 million in Q1 2026.

• For the quarter ending Q1 2026, Shares Outstanding (Entity) rose 1.25% year-over-year to $36.6 million; the trailing twelve-month figure through Mar 2026 stood at $36.6 million (up 1.25% YoY), and the FY2025 full-year result was $36.4 million, up 0.69% from the prior year.
• Shares Outstanding (Entity) climbed to $36.6 million in Q1 2026, from $36.4 million in the prior quarter.
• In the past five years, Shares Outstanding (Entity) ranged from a high of $36.6 million in Q1 2026 to a low of $29.0 million in Q1 2022.
• A 5-year average of $35.8 million and a median of $36.1 million in 2022 frame the typical range for Shares Outstanding (Entity).
• Across the five-year window, Shares Outstanding (Entity) jumped 44.87% in 2022 and slipped 0.06% in 2023, its largest moves.
• Tracing ARMP's Shares Outstanding (Entity) over 5 years: stood at $36.1 million in 2022, then fell by 0.06% to $36.1 million in 2023, then climbed by 0.17% to $36.2 million in 2024, then climbed by 0.69% to $36.4 million in 2025, then advanced by 0.59% to $36.6 million in 2026.
• Business Quant data shows ARMP's Shares Outstanding (Entity) at $36.6 million in Q1 2026, $36.4 million in Q4 2025, and $36.2 million in Q3 2025.